BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 25486993)

  • 1. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.
    Kaakoush NO; Deshpande NP; Man SM; Burgos-Portugal JA; Khattak FA; Raftery MJ; Wilkins MR; Mitchell HM
    Infect Immun; 2015 Feb; 83(2):832-45. PubMed ID: 25486993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases.
    Kaakoush NO; Deshpande NP; Wilkins MR; Tan CG; Burgos-Portugal JA; Raftery MJ; Day AS; Lemberg DA; Mitchell H
    PLoS One; 2011; 6(12):e29045. PubMed ID: 22194985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Campylobacter concisus as the etiologic agent of gastrointestinal diseases.
    Akutko K; Matusiewicz K
    Adv Clin Exp Med; 2017; 26(1):149-154. PubMed ID: 28397447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen.
    Kovach Z; Kaakoush NO; Lamb S; Zhang L; Raftery MJ; Mitchell H
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):387-96. PubMed ID: 22092566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The susceptibility of Campylobacter concisus to the bactericidal effects of normal human serum.
    Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2015 Mar; 123(3):269-74. PubMed ID: 25627875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data.
    Aabenhus R; On SL; Siemer BL; Permin H; Andersen LP
    J Clin Microbiol; 2005 Oct; 43(10):5091-6. PubMed ID: 16207968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells.
    Deshpande NP; Wilkins MR; Castaño-Rodríguez N; Bainbridge E; Sodhi N; Riordan SM; Mitchell HM; Kaakoush NO
    Sci Rep; 2016 Sep; 6():34288. PubMed ID: 27677841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-Mediated Aggravation of the
    Nattramilarasu PK; Lobo de Sá FD; Schulzke JD; Bücker R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669494
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoglobulin G response in patients with Campylobacter concisus diarrhea.
    Nielsen HL; Kaakoush NO; Mitchell HM; Nielsen H
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):151-4. PubMed ID: 26643061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomics of Campylobacter concisus: Analysis of clinical strains reveals genome diversity and pathogenic potential.
    Gemmell MR; Berry S; Mukhopadhya I; Hansen R; Nielsen HL; Bajaj-Elliott M; Nielsen H; Hold GL
    Emerg Microbes Infect; 2018 Jun; 7(1):116. PubMed ID: 29946138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomics of Campylobacter concisus isolates reveals genetic diversity and provides insights into disease association.
    Deshpande NP; Kaakoush NO; Wilkins MR; Mitchell HM
    BMC Genomics; 2013 Aug; 14():585. PubMed ID: 23984967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motility of Campylobacter concisus isolated from saliva, feces, and gut mucosal biopsies.
    Ovesen S; Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2017 Mar; 125(3):230-235. PubMed ID: 28116789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter concisus - A new player in intestinal disease.
    Kaakoush NO; Mitchell HM
    Front Cell Infect Microbiol; 2012; 2():4. PubMed ID: 22919596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Importance of
    Liu F; Ma R; Wang Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():243. PubMed ID: 30087857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of emerging Campylobacter species in inflammatory bowel diseases.
    Kaakoush NO; Mitchell HM; Man SM
    Inflamm Bowel Dis; 2014 Nov; 20(11):2189-97. PubMed ID: 24874462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First attempt to produce experimental Campylobacter concisus infection in mice.
    Aabenhus R; Stenram U; Andersen LP; Permin H; Ljungh A
    World J Gastroenterol; 2008 Dec; 14(45):6954-9. PubMed ID: 19058331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression.
    Elling R; Chan J; Fitzgerald KA
    Eur J Immunol; 2016 Mar; 46(3):504-12. PubMed ID: 26820238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.